GSK executives in China to handle the scandal
2013-7-22
Three top executives from scandal-ridden British company GlaxoSmithKline are in China to deal with a rising storm over corruption allegations. The pharmaceutical giant issued an apology statement on July 15th in response to the investigation launched by China.
On Monday, Chinese police charged GSK for bribing officials and doctors to boost sales and raise the price of its medicines in China. They said GSK transferred up to 489 million dollars to 700 travel agencies and consultancies over six years to facilitate the bribes.
The police also said they have plenty of evidence that some high rank officials of GSK and related travel agencies have been involved in tax-related crimes and commercial bribery.
Hot news
- US tariffs on Chinese exports of tires s...
- Dyson hopes to clean up in China
- Chevron confirms China shale work
- EU imports face dumping probe
- China to cut overcapacity
- China Focus: Oil import license ends sta...
- Chinese hi-tech park settles in Silicon ...
- China's cement industry sets, as investm...
- China's external debt on the rise
- Foreign central banks allowed on China's...
The latest report
- Investment Environment Analysis and Fore...
- China Real Estate Market Research Report
- China Real Estate Finance Industry Resea...
- China Internet Finance Industry Research...
- China Financial Leasing Industry Researc...
- China Tourism Real Estate Market Researc...
- China Private Bank Industry Research Rep...
- China First-tier Cities Real Estate Mark...
- China Wind Energy Industry Research Repo...
- China Ocean Energy Industry Research Rep...